The European Larynx Organ Preservation Study [MK-3475-C44]
Gunnar Wichmann(Leipzig University of Applied Sciences), Andreas Dietz(Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde), J. Vogt(University Hospital Leipzig), Peter Hambsch(Leipzig University), Matthaeus Stoehr(University Hospital Leipzig), Markus Pirlich(University Hospital Leipzig), Jens Peter Klußmann(Lungenklinik Köln-Merheim), Ralf Tostmann(University of Göttingen), Thomas Kuhnt(Leipzig University), Orlando Guntinas‐Lichius(Jena University Hospital), Veit Zebralla(University Hospital Leipzig), Kathrin Vogel(University Hospital Leipzig), Susanne Wiegand, Thomas Asendorf, Nils H. Nicolay(University Hospital Leipzig), Ina Münter, Joanna Napp(Max Planck Institute of Experimental Medicine), Sylvia Meuret(University Hospital Leipzig), Theresa Wald(University Hospital Leipzig)
Cited by 8
Related Papers
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
|Journal of Clinical Oncology|2019|550
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
|JAMA Oncology|2021|369
Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis
|The Lancet Oncology|2023|291
Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas
|International Journal of Radiation Oncology*Biology*Physics|2000|218